GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Moberg Pharma AB (FRA:MB8) » Definitions » Shiller PE Ratio

Moberg Pharma AB (FRA:MB8) Shiller PE Ratio : 0.28 (As of Apr. 25, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Moberg Pharma AB Shiller PE Ratio?

As of today (2025-04-25), Moberg Pharma AB's current share price is €0.6845. Moberg Pharma AB's E10 for the quarter that ended in Dec. 2024 was €2.48. Moberg Pharma AB's Shiller PE Ratio for today is 0.28.

The historical rank and industry rank for Moberg Pharma AB's Shiller PE Ratio or its related term are showing as below:

FRA:MB8' s Shiller PE Ratio Range Over the Past 10 Years
Min: 0.15   Med: 1.09   Max: 18.76
Current: 0.26

During the past years, Moberg Pharma AB's highest Shiller PE Ratio was 18.76. The lowest was 0.15. And the median was 1.09.

FRA:MB8's Shiller PE Ratio is ranked better than
99.42% of 521 companies
in the Drug Manufacturers industry
Industry Median: 23.88 vs FRA:MB8: 0.26

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Moberg Pharma AB's adjusted earnings per share data for the three months ended in Dec. 2024 was €-0.453. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is €2.48 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Moberg Pharma AB Shiller PE Ratio Historical Data

The historical data trend for Moberg Pharma AB's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moberg Pharma AB Shiller PE Ratio Chart

Moberg Pharma AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.81 1.19 0.54 0.49 0.34

Moberg Pharma AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.49 0.73 0.94 0.33 0.34

Competitive Comparison of Moberg Pharma AB's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Moberg Pharma AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moberg Pharma AB's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Moberg Pharma AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Moberg Pharma AB's Shiller PE Ratio falls into.


;
;

Moberg Pharma AB Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Moberg Pharma AB's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=0.6845/2.48
=0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Moberg Pharma AB's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, Moberg Pharma AB's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.453/132.9872*132.9872
=-0.453

Current CPI (Dec. 2024) = 132.9872.

Moberg Pharma AB Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201412 -0.018 100.225 -0.024
201503 0.462 99.950 0.615
201506 0.233 99.995 0.310
201509 0.370 100.228 0.491
201512 0.000 100.276 0.000
201603 -0.245 100.751 -0.323
201606 1.196 101.019 1.574
201609 0.529 101.138 0.696
201612 -0.117 102.022 -0.153
201703 -0.101 102.022 -0.132
201706 -0.263 102.752 -0.340
201709 0.423 103.279 0.545
201712 0.315 103.793 0.404
201803 0.067 103.962 0.086
201806 0.149 104.875 0.189
201809 0.065 105.679 0.082
201812 0.349 105.912 0.438
201903 17.321 105.886 21.754
201906 1.874 106.742 2.335
201909 0.937 107.214 1.162
202003 -0.107 106.563 -0.134
202006 -0.172 107.498 -0.213
202009 -0.154 107.635 -0.190
202012 -0.215 108.296 -0.264
202103 0.297 108.360 0.365
202106 -0.053 108.928 -0.065
202109 -0.059 110.338 -0.071
202112 -0.065 112.486 -0.077
202203 -0.063 114.825 -0.073
202206 -0.039 118.384 -0.044
202209 -0.040 122.296 -0.043
202212 -0.021 126.365 -0.022
202303 -0.045 127.042 -0.047
202306 -0.033 129.407 -0.034
202309 -0.030 130.224 -0.031
202312 -0.021 131.912 -0.021
202403 -0.020 132.205 -0.020
202406 -0.012 132.716 -0.012
202409 -0.003 132.304 -0.003
202412 -0.453 132.987 -0.453

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Moberg Pharma AB  (FRA:MB8) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Moberg Pharma AB Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Moberg Pharma AB's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Moberg Pharma AB Business Description

Traded in Other Exchanges
Address
Gustavslundsvagen 42, 5th Floor, Bromma, Stockholm, SWE, SE-167 51
Moberg Pharma AB is a Swedish pharmaceutical company focused on commercializing proprietary innovations based on drug delivery of compounds. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. The Company's main product, MOB-015, is a novel topical treatment for onychomycosis It has a single operating segment, the development, and commercialization of medical products. Its geographic areas are Europe, the Americas, and Rest of the world.

Moberg Pharma AB Headlines

No Headlines